QA: Evoke Pharma Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001403708_2023_Evoke_Pharma_Inc.pdf

Logs

Graph

Absolute values for 0001403708, Evoke Pharma Inc

  xvar xval
0 AssetsCurrent 11,722,414
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 129,074
4 LiabilitiesCurrent 1,654,544
5 LiabilitiesNoncurrent 6,112,295
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,623,599
9 ResearchAndDevelopmentExpense 300,789
10 remainder_Expenses 370,394
11 remainder_Revenues 2,508,645
12 remainder_NetIncome -437,993
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 11,851,488
1 Liabilities 7,766,839
2 Expenses 10,294,782
3 Revenues 2,508,645
4 StockholdersEquity 4,084,649
5 NetIncome -8,224,130
6 ComprehensiveNetIncome -8,224,130
7 BaseVar 16,429,874
8 EconomicCapitalRatio -0.122

Edgar->Model Mapping

Feature Distribution

Change over Time